Friday Links

Why is NIH funding small trials? (there’s a good reason!) First bird flu death in humans. Employee responses to CEO activism. How rich were the rich? ‘Hot hand’ and fantasy baseball.

Time is money in drug development

Delays in drug approvals cost pharmaceutical firms money. These costs include both lost sales as well as additional cost if clinical trials need to span a longer duration. While these facts are not in doubt, a key question is how much do delays in approval cost firms? A paper by Smith, DiMasi and Getz (2024)…